AU710492B2 - Thiepane compounds inhibiting and detecting HIV protease - Google Patents

Thiepane compounds inhibiting and detecting HIV protease Download PDF

Info

Publication number
AU710492B2
AU710492B2 AU42342/96A AU4234296A AU710492B2 AU 710492 B2 AU710492 B2 AU 710492B2 AU 42342/96 A AU42342/96 A AU 42342/96A AU 4234296 A AU4234296 A AU 4234296A AU 710492 B2 AU710492 B2 AU 710492B2
Authority
AU
Australia
Prior art keywords
prt
compound
independently
groups
oprt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU42342/96A
Other languages
English (en)
Other versions
AU4234296A (en
Inventor
Norbert W Bischofberger
Choung U. Kim
Steven H Krawczyk
Lawrence R. Mcgee
Michael J. Postich
Wenjin Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/473,876 external-priority patent/US5705524A/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AU4234296A publication Critical patent/AU4234296A/en
Application granted granted Critical
Publication of AU710492B2 publication Critical patent/AU710492B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/04Seven-membered rings not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU42342/96A 1994-11-04 1995-11-03 Thiepane compounds inhibiting and detecting HIV protease Expired AU710492B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US33447194A 1994-11-04 1994-11-04
US08/334471 1994-11-04
US47086495A 1995-06-06 1995-06-06
US08/470864 1995-06-06
US08/473,876 US5705524A (en) 1994-11-04 1995-06-07 Thiepane compounds
US08/473876 1995-06-07
US52204295A 1995-11-02 1995-11-02
US08/522042 1995-11-02
PCT/US1995/014603 WO1996014314A2 (en) 1994-11-04 1995-11-03 Thiepane compounds inhibiting and detecting hiv protease

Publications (2)

Publication Number Publication Date
AU4234296A AU4234296A (en) 1996-05-31
AU710492B2 true AU710492B2 (en) 1999-09-23

Family

ID=27502493

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42342/96A Expired AU710492B2 (en) 1994-11-04 1995-11-03 Thiepane compounds inhibiting and detecting HIV protease

Country Status (5)

Country Link
EP (1) EP0789695A2 (ja)
JP (1) JP2002515849A (ja)
AU (1) AU710492B2 (ja)
CA (1) CA2203570A1 (ja)
WO (1) WO1996014314A2 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
SG45864A1 (en) 1995-02-27 1999-04-27 Novel selective inhibitors of viral or bacterial neuraminidases
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US5994377A (en) 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
ATE367394T1 (de) 2002-04-26 2007-08-15 Gilead Sciences Inc Anreicherung in der zelle an phosphonat analoga von hiv protease inhibitor verbindungen und die verbindungen selbst
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7300924B2 (en) 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
WO2004096287A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
AU2004233897A1 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Kinase inhibitor phosphonate conjugates
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
MXPA05011297A (es) 2003-04-25 2006-05-25 Gilead Sciences Inc Analogos antivirales de fosfonato.
EP1680512A1 (en) 2003-10-24 2006-07-19 Gilead Sciences, Inc. Methods and compositions for identifying therapeutic compounds
WO2005044308A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
WO2005044279A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Purine nucleoside phosphonate conjugates
ATE424400T1 (de) 2003-12-22 2009-03-15 Gilead Sciences Inc 4'-substituierte carbovir- und abacavir-derivate sowie verwandte verbindungen mit hiv- und hcv- antiviraler wirkung
ES2363160T3 (es) 2004-07-27 2011-07-22 Gilead Sciences, Inc. Conjugados de fosfonato nucelosidico como agentes anti-vih.
JP5620376B2 (ja) 2008-07-08 2014-11-05 ギリアード サイエンシーズ, インコーポレイテッド Hiv阻害剤化合物の塩
US10851125B2 (en) 2017-08-01 2020-12-01 Gilead Sciences, Inc. Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl(-L-alaninate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007128A1 (en) * 1991-10-11 1993-04-15 The Du Pont Merck Pharmaceutical Company Cyclic ureas and analogues useful as retroviral protease inhibitiors
WO1994019329A1 (en) * 1993-02-26 1994-09-01 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9122391A (en) * 1990-11-30 1992-06-25 Smithkline Beecham Corporation Hiv protease inhibitors
US5514801A (en) * 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
JPH09500120A (ja) * 1993-07-14 1997-01-07 チバ−ガイギー アクチェンゲゼルシャフト 環式ヒドラジン化合物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007128A1 (en) * 1991-10-11 1993-04-15 The Du Pont Merck Pharmaceutical Company Cyclic ureas and analogues useful as retroviral protease inhibitiors
WO1994019329A1 (en) * 1993-02-26 1994-09-01 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors

Also Published As

Publication number Publication date
JP2002515849A (ja) 2002-05-28
WO1996014314A3 (en) 1996-06-20
WO1996014314A2 (en) 1996-05-17
EP0789695A2 (en) 1997-08-20
AU4234296A (en) 1996-05-31
CA2203570A1 (en) 1996-05-17

Similar Documents

Publication Publication Date Title
AU710492B2 (en) Thiepane compounds inhibiting and detecting HIV protease
US5705524A (en) Thiepane compounds
US6034118A (en) Thiepane compounds
JP3622983B2 (ja) シクロヘキセンカルボキシレート誘導体の調製
US5763483A (en) Carbocyclic compounds
JP4234917B2 (ja) ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
US5866601A (en) Carbocyclic compounds
US5886213A (en) Preparation of carbocyclic compounds
KR100564891B1 (ko) 사이클로헥센 카복실레이트 유도체의 제조 방법
CS205087B2 (en) Method of producing hydroxy-and oxoderivatives of aryloxy-and arylthio-perhydro-aza heterocycles
JP2008273948A (ja) ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
US3250778A (en) Intermediates for and synthesis of vitamin b and related compounds
HU176897B (en) Process for preparing 3-/cyanimino/-3-amino-propionitrile derivatives
US5811450A (en) Thiepane compounds
US5958973A (en) Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
DK143199B (da) Racemiske eller optisk aktive 2-oxabicyclo (3,3,0) octaner til anvendelse som mellemprodukter ved fremstilling af prostaglandinforbindelser og fremgangsmaade til fremstilling deraf
KR870000234B1 (ko) 트랜스-dI-5-치환된-7-임의 치환된-4,4a,5,6,7,8,8a,9-옥타하이드로-1H(및 2H)피라졸로[3,4-g] 퀴나졸린의 제조 방법
JPS6135194B2 (ja)
Aatif et al. Synthesis of novel [1, 2, 4] triazolo [3, 4-d][1, 5] benzodiazepinones derivatives by 1, 3-dipolar cycloaddition
DK164057B (da) Oe5,6aa-cis-1,3-oxathianderivater og fremgangsmaade til deres fremstilling og farmaceutisk middel indeholdende et saadant derivat
SU833157A3 (ru) Способ получени производных циклододекана или их оптическиАКТиВНыХ изОМЕРОВ B СВОбОдНОМ ВидЕ,B ВидЕ СОли или чЕТВЕРТич-НыХ АММОНиЕВыХ пРОизВОдНыХ
US20020156300A1 (en) Preparation of cyclohexene carboxylate derivatives
US3657439A (en) 5 - aryloxyatricyclo(3.2.2.0**2 4)nonane - 1-amines in antidepressant compositions and methods
RU2207340C2 (ru) Способ получения 1,2,3,9-тетрагидро-9-метил-3-[(2-метил-1н-имидазол-1-ил)метил]-4н-карбазол -4-она или его фармацевтически приемлемых солей
US4029665A (en) 8-Aralkyl-1,4-ethano-5H-[1]benzopyrano[3,4-b]pyridines